BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/24/0.1/21.06.24 Stock

Warrant

7ZLNB

NLBNPFR1WXD6

Market Closed - Euronext Paris 12:30:01 2024-06-04 pm EDT
0.015 EUR 0.00% Intraday chart for BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/24/0.1/21.06.24
3 months-82.35%
Current year-76.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-04 0.015 0.00%
24-06-03 0.015 0.00%
24-05-31 0.015 0.00%
24-05-30 0.015 0.00%
24-05-29 0.015 0.00%

Real-time Euronext Paris

Last update June 04, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
7ZLNB
ISINNLBNPFR1WXD6
Date issued 2023-12-15
Strike 24 $
Maturity 2024-06-21 (17 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.13
Lowest since issue 0.015
Delta-0.08x
Omega 14.19
Premium17.78x
Gearing172.07x
Moneyness 0.8280
Difference Strike -5.49 $
Difference Strike %-22.88%
Spread 0.029
Spread %96.67%
Theoretical value 0.0155
Implied Volatility 66.73 %
Total Loss Probability 89.44 %
Intrinsic value 0.000000
Present value 0.0155
Break even 23.83 €
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.49 USD
Average target price
31.92 USD
Spread / Average Target
+8.22%
Consensus
  1. Stock Market
  2. Warrants
  3. 7ZLNB Warrant